IC
CRDF icon

IEQ Capital’s Cardiff Oncology CRDF Stock Holding History

IEQ Capital’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$58K Buy
+44,630
New +$70.9K ﹤0.01% 1980

Other funds holding CRDF

LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

IEQ Capital's CRDF Position: Q2 2026 in Review

IEQ Capital opened a new position in Cardiff Oncology (CRDF) in Q2 2026: 44,630 shares worth $58K. The stake represents ﹤0.01% of the portfolio and ranks #1980 among its holdings.

105 funds tracked by Wall St. Rank hold CRDF as of Q2 2026.

  • IEQ Capital held 44,630 shares of Cardiff Oncology worth $58K as of Q2 2026.
  • Cardiff Oncology was a new IEQ Capital position in Q2 2026.
  • Cardiff Oncology made up ﹤0.01% of IEQ Capital's portfolio in Q2 2026, its #1980 holding.
  • 105 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.